Lipocine, Inc. (LPCN)
2.315
+0.06
(+2.89%)
USD |
NASDAQ |
Sep 10, 16:00
2.315
0.00 (0.00%)
After-Hours: 16:25
Lipocine Shareholders Equity (Quarterly) : 21.77M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.77M |
| March 31, 2026 | 22.83M |
| December 31, 2025 | 14.48M |
| September 30, 2025 | 14.14M |
| June 30, 2025 | 17.13M |
| March 31, 2025 | 19.20M |
| December 31, 2024 | 21.00M |
| September 30, 2024 | 19.12M |
| June 30, 2024 | 21.21M |
| March 31, 2024 | 23.96M |
| December 31, 2023 | 20.37M |
| September 30, 2023 | 22.48M |
| June 30, 2023 | 28.55M |
| March 31, 2023 | 31.96M |
| December 31, 2022 | 35.63M |
| September 30, 2022 | 37.65M |
| June 30, 2022 | 39.89M |
| March 31, 2022 | 42.41M |
| December 31, 2021 | 45.57M |
| September 30, 2021 | 32.81M |
| June 30, 2021 | 35.75M |
| March 31, 2021 | 42.39M |
| December 31, 2020 | 15.34M |
| September 30, 2020 | 14.51M |
| June 30, 2020 | 13.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.553M |
| December 31, 2019 | 6.288M |
| September 30, 2019 | 7.505M |
| June 30, 2019 | 9.850M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 9.434M |
| September 30, 2018 | 11.76M |
| June 30, 2018 | 13.88M |
| March 31, 2018 | 16.67M |
| December 31, 2017 | 18.98M |
| September 30, 2017 | 23.77M |
| June 30, 2017 | 25.15M |
| March 31, 2017 | 24.88M |
| December 31, 2016 | 26.02M |
| September 30, 2016 | 27.98M |
| June 30, 2016 | 30.76M |
| March 31, 2016 | 35.78M |
| December 31, 2015 | 41.99M |
| September 30, 2015 | 46.25M |
| June 30, 2015 | 52.13M |
| March 31, 2015 | 23.72M |
| December 31, 2014 | 26.36M |
| September 30, 2014 | 29.96M |
| June 30, 2014 | 33.82M |
| March 31, 2014 | 40.60M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.84M |
| Total Liabilities (Quarterly) | 2.068M |
| Current Ratio | 11.48 |